Table 1 |.
Colonized (n = 46) | Not colonized (n = 11) | OR (95% CI) | P value | |
---|---|---|---|---|
| ||||
Length of stay (d) between admission and first swab (M ± IQR) | 361 ± 801 | 571 ± 1,372 | 1.00 (0.99,1.00) | 0.26 |
Age in years (mean ± s.d.) | 59 ± 14 | 59 ± 14 | 1.00 (0.95,1.05) | 0.89 |
Female (n (%)) | 18 (39) | 5 (45) | 0.77 (0.20,2.91) | 0.74 |
African American (n (%)) | 31 (74) | 9 (90) | 0.31 (0.066,2.76) | 0.42 |
Mechanical ventilation (n (%)) | 23 (50) | 0 (0) | 23.00 (1.28,413.3) | 0.002 |
Gastrostomy tube (n (%)) | 35(78) | 3 (27) | 9.33 (2.08,41.89) | 0.003 |
Tracheostomy (n (%)) | 34 (74) | 6 (55) | 2.36 (0.61,9.17) | 0.27 |
Urinary catheter (n (%)) | 33 (72) | 3 (27) | 6.77 (1.55,29.56) | 0.012 |
Hospital stay within past 90d (n (%)) | 20 (44) | 3 (27) | 2.13 (0.50,9.11) | 0.5 |
Charlson comorbidity index (M ± IQR) | 3 ± 2 | 3 ± 2 | 0.91 (0.65,1.28) | 0.59 |
Congestive heart failure (n (%)) | 10 (22) | 5 (45) | 0.33 (0.084,1.32) | 0.11 |
Chronic lung disease (n (%)) | 36(78) | 6 (55) | 3.00 (0.76,11.90) | 0.11 |
Braden scale scorea (mean ± s.d.) | 13 ± 2 | 16 ± 5 | 0.74 (0.59,0.94) | 0.013 |
History of carbapenemase- producing bacterial colonization or infectionb | 31 (67) | 6 (55) | 1.72 (0.45,6.56) | 0.49 |
Antibacterial receipt in prior 90 d (n (%)) | 34 (74) | 5 (45) | 3.4 (0.88,13.21) | 0.030 |
Antifungal receipt in prior 90 d (n (%)) | 5 (11) | 0 (0) | 3.05 (0.16,59.29) | 0.57 |
The Braden Scale for Predicting Pressure Sore Risk assesses a person’s risk of developing a pressure ulcer by examining six criteria: moisture, activity, mobility, nutrition and friction and shear.
Screening of facility residents for carbapenemase-producing bacterial colonization was performed routinely. Screening for colonization by other multidrug-resistant organisms was not performed.
CI, confidence interval; IQR, interquartile range; M, median; OR, odds ratio.